(Q39112720)

9 September 2017

title

MicroRNA-106a induces multidrug resistance in gastric cancer by targeting RUNX3. (English)

1 reference

9 September 2017

1 reference

multiple drug resistance

1 reference

Yi Zhang

1

1 reference

9 September 2017

Qiping Lu

series ordinal

2

1 reference

9 September 2017

Xun Cai

series ordinal

3

1 reference

9 September 2017

language of work or name

English

0 references

publication date

8 August 2013

1 reference

9 September 2017

1 reference

9 September 2017

volume

587

1 reference

9 September 2017

issue

18

1 reference

9 September 2017

page(s)

3069-3075

1 reference

Prognostic factors for stage IV gastric cancer

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.058

Targeting multidrug resistance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.058

Assessment of multidrug resistance on cell coculture patterns using scanning electrochemical microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.058

miR-297 modulates multidrug resistance in human colorectal carcinoma by down-regulating MRP-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.058

miR-1915 inhibits Bcl-2 to modulate multidrug resistance by increasing drug-sensitivity in human colorectal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.058

Genome-wide epigenetic regulation of miRNAs in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.058

Regulation of miR-19 to breast cancer chemoresistance through targeting PTEN

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.058

miR-106a overexpression and pRB downregulation in sporadic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.058

Retroviral activation of the mir-106a microRNA cistron in T lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.058

miR-106a is frequently upregulated in gastric cancer and inhibits the extrinsic apoptotic pathway by targeting FAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.058

Detection of miR-106a in gastric carcinoma and its clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.058

CacyBP/SIP enhances multidrug resistance of pancreatic cancer cells by regulation of P-gp and Bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.058

MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.058

miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.058

miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.058

miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.058

Growth-promoting role of the miR-106a~363 cluster in Ewing sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.058

Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.058

Proteasome inhibitor MG132 reverses multidrug resistance of gastric cancer through enhancing apoptosis and inhibiting P-gp

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.058

The RUNX family in breast cancer: relationships with estrogen signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.058

Epigenetic changes induced by oxidative stress in colorectal cancer cells: methylation of tumor suppressor RUNX3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.058

RUNX3 expression is lost in glioma and its restoration causes drastic suppression of tumor invasion and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.058

Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.058

Tumor suppressor gene Runx3 sensitizes gastric cancer cells to chemotherapeutic drugs by downregulating Bcl-2, MDR-1 and MRP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.058

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.058

Differentially expressed gene profiles between multidrug resistant gastric adenocarcinoma cells and their parental cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.058

10.1016/J.FEBSLET.2013.06.058

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference